312-422-1111 ibioadmin@ibio.org

october, 2019

08oct4:30 PM6:30 PMGoing Big or Small: Strategies for Venture Backed Biotech Startups

Event Details

CEO of Accelerator Life Science Partners shares how his firm catalyzes the development and commercialization of breakthrough biotechnology.

About this Event

Thong Q. Le serves as President and Chief Executive Officer (CEO) of Accelerator Life Science Partners. With more than 20 years of experience in identifying, investing, managing, and successfully exiting numerous seed and early-stage investments, Mr. Le is positioned to grow and expand the Accelerator investment model. He currently serves as CEO and Director of all Accelerator Life Science Partner I portfolio companies, which currently includes ApoGen Biotechnologies, Lodo Therapeutics, Magnolia Neurosciences, Proniras Corporation, and Rodeo Therapeutics. He also serves as a Director of Acylin Therapeutics, AgTech Accelerator, and Petra Pharma (where he served as the company’s initial CEO).

Prior to becoming CEO at Accelerator, Mr. Le served as a Managing Director at WRF Capital, the venture capital investment arm of Washington Research Foundation in Seattle, WA. During his 13-year tenure at WRF Capital, Mr. Le played a significant role in the early sourcing, financing, and development of numerous start-up companies, including Alder Biopharmaceuticals (NASDAQ: ALDR), Corus Pharma (acquired by Gilead Sciences), Halosource (LSE: HALO.L), Hyperion Therapeutics (Nasdaq: HPTX), Lumera (NasdaqNM: LMRA), Performant (acquired by Mercury Interactive), Pathway Medical Technologies (acquired by MEDRAD), and VLST (asset acquisition by major international pharmaceutical company). He also led WRF Capital’s investments in Accelerator, AnswerDash, ARZEDA, Cardeas Pharma, Resolve Therapeutics, and Uptake Medical, all companies where he was actively involved in establishing as a founding or early investor.

Prior to joining WRF Capital, Mr. Le was the founder, president and CEO of MiniMeals, Inc. and a consultant for Capital Management Consulting, Inc. Earlier, he was at Raymond James & Associates, Singer & Xenos Investment Management Company and Capital Management Group LLC, a private investment firm specializing in biomedical ventures.

Mr. Le completed post-graduate studies at the Templeton College of Oxford University and earned a bachelor of arts cum laude in government from Harvard University. He currently serves on the advisory board for the Alexandria Seed Capital Platform and on the executive committees of the Evergreen Venture Capital Association (EVCA) and Washington Global Health Fund. He was previously named one of the region’s “40 Under 40” by the Puget Sound Business Journal.


(Tuesday) 4:30 PM - 6:30 PM


Rosalind Franklin University

3333 Green Bay Road


SmarthHealth Activator

Submit a Comment

Your email address will not be published. Required fields are marked *